Prognostic Impact of Molecular Mutations in AML at First Relapse

Anjali S. Advani,Paul Elson,Valeria Visconte,Jennifer S. Carew,Jaime Fensterl,Bartlomiej Przychodzen, Mikkael A. Sekeres,Cassandra M. Hirsch,Alek Nielsen,John Desamito,Hetty E. Carraway,Aaron T. Gerds,Betty K. Hamilton,Sudipto Mukherjee,Ronald M. Sobecks,Matt Kalaycio,Yogen Saunthararajah,Jaroslaw P. Maciejewski

Blood（2015）

引用 23|浏览22

暂无评分

摘要

Molecular mutations are routinely incorporated into the risk stratification of newly diagnosed acute myeloid leukemia (AML) patients (pts). However, their prognostic impact in relapsed AML has not been well characterized. To better understand the landscape and prognostic impact of molecular mutations in relapsed AML, we retrospectively examined pts with AML in first relapse.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要